Pan-cancer analysis supports MAPK12 as a potential prognostic and immunotherapeutic target in multiple tumor types, including in THCA

P38 mitogen-activated protein kinase (MAPK)12 (also known as P38 γ) is critical in the development and progression of various types of tumors. Despite the extensive literature on the subject, further studies are needed to elucidate its role in cancer progression. Here, a comprehensive bioinformatics...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jinju, Song, Zhe, Ren, Li, Zhang, Bowei, Zhang, Yun, Yang, Xianwei, Liu, Tong, Gu, Yi, Feng, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647794/
https://www.ncbi.nlm.nih.gov/pubmed/36420075
http://dx.doi.org/10.3892/ol.2022.13565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647794/
https://www.ncbi.nlm.nih.gov/pubmed/36420075
http://dx.doi.org/10.3892/ol.2022.13565

Ejemplares similares